@article{Giglia_Beci_Rosselli Del Turco_Guardigni_Amedeo_Cucchetto_Verucchi_Cipolli_Calza_Viale_2020, title={SARS-CoV-2 related pneumonia in an adult with cystic fibrosis: natural favourable clinical course or effective therapy?}, volume={90}, url={https://www.monaldi-archives.org/macd/article/view/1579}, DOI={10.4081/monaldi.2020.1579}, abstractNote={<p>We report the case of a man affected by cystic fibrosis who developed a severe SARS-CoV-2 related pneumonia in March 2020. In addition to lopinavir/ritonavir and hydroxychloroquine, he was treated with two doses of tocilizumab, displaying a significant clinical improvement. This is the first case described in the literature of an adult patient affected by cystic fibrosis who received tocilizumab for COVID-19, with documented total recovery, also assessed by a spirometry.</p>}, number={4}, journal={Monaldi Archives for Chest Disease}, author={Giglia, Maddalena and Beci, Giacomo and Rosselli Del Turco, Elena and Guardigni, Viola and Amedeo, Alberto and Cucchetto, Giulia and Verucchi, Gabriella and Cipolli, Marco and Calza, Leonardo and Viale, Pierluigi}, year={2020}, month={Dec.} }